Home › Borstkanker › Utah › Salt Lake City
Borstkanker klinische studies in Salt Lake City, UT
27 studies voor Borstkanker zoeken deelnemers op locaties in en rond Salt Lake City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruterenFase 3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruterenFase 3
- Clinical Trial Site, Salt Lake City
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- Utah Cancer Specialists, Salt Lake City
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekruterenFase 2
- Huntsman Cancer Institute, Salt Lake City
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Utah Cancer Specialists, Salt Lake City
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RekruterenFase 1/2
- University of Utah Huntsman Cancer Institute, Salt Lake City
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruterenFase 3
- Huntsman Cancer Hospital at the University of Utah, Salt Lake City
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- Farmington Health Center, Farmington · 15 mijl verwijderd
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruterenFase 1
- Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
RekruterenFase 2
- Huntsman Cancer Institute at University of Utah, Salt Lake City
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruterenFase 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruterenFase 1/2
- Huntsman Cancer Institute, Salt Lake City
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruterenFase 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekruteren
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- Utah Cancer Specialists-Salt Lake City, Salt Lake City
- LDS Hospital, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruterenFase 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
RekruterenVroege fase 1
- Huntsman Cancer Institute at University of Utah, Salt Lake City
Improving Care for Rural Patients With Solid Tumors
Rekruteren
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
RekruterenFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
SAVE Trial: SAfe Opioid Use Video Education
Rekruteren
- University of Utah Huntsman Cancer Institute, Salt Lake City
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
RekruterenGezonde vrijwilligers welkom
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Salt Lake City
Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
RekruterenFase 3
- Huntsman Cancer Institute at University of Utah, Salt Lake City
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
RekruterenFase 1
- University of Utah- Huntsman Cancer Center, Salt Lake City
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
Rekruteren
- University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences, Salt Lake City
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Salt Lake City
- Niet-kleincellige longkanker31 studies
- Kanker (alle vormen)27 studies
- Colorectale kanker22 studies
- Longkanker21 studies
- Melanoom21 studies
- Multipel myeloom21 studies
- Metastatische kanker20 studies
- Eierstokkanker19 studies
- Obesitas18 studies
- Acute myeloïde leukemie17 studies
- Hartfalen17 studies
- Prostaatkanker15 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.